0001189724-17-000003.txt : 20170227
0001189724-17-000003.hdr.sgml : 20170227
20170227141238
ACCESSION NUMBER: 0001189724-17-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170224
FILED AS OF DATE: 20170227
DATE AS OF CHANGE: 20170227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RIGGS STEVEN
CENTRAL INDEX KEY: 0001189724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 17640966
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL INC
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-02-24
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001189724
RIGGS STEVEN
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP Operations
Common Stock
2017-02-24
4
X
0
16250
58.79
A
17576
D
Common Stock
2017-02-24
4
S
0
4500
151.3881
D
13076
D
Common Stock
2017-02-24
4
S
0
11750
152.2282
D
1326
D
Common Stock
2017-02-24
4
X
0
15000
58.79
A
16326
D
Common Stock
2017-02-24
4
S
0
4796
151.4907
D
11530
D
Common Stock
2017-02-24
4
S
0
10204
152.2044
D
1326
D
Non-Qualified Stock Option (right to buy)
58.79
2017-02-24
4
X
0
16250
58.79
D
2024-02-24
Common Stock
16250
46250
D
Non-Qualified Stock Option (right to buy)
58.79
2017-02-24
4
X
0
15000
58.79
D
2024-02-24
Common Stock
15000
31250
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire, Attorney-in-fact For: Steven C. Riggs
2017-02-27